About the Gallbladder Cancer Session
Gallbladder cancer, though uncommon, is a particularly aggressive form of cancer that begins in the cells lining the gallbladder. Cutting-edge research has been dedicated to uncovering the genetic mutations and molecular mechanisms that drive this disease. Advances in imaging technologies and biomarker identification have become pivotal for early diagnosis. Genomic sequencing has revealed critical mutations in genes such as TP53, KRAS, and ERBB2, paving the way for targeted treatments. Additionally, novel therapies, including immunotherapy, are showing promise in improving patient outcomes. Ongoing research efforts are essential to develop effective diagnostic and therapeutic approaches for this formidable cancer.
Topics Covered in Gallbladder Cancer
Gallstones & Inflammation
Staging & Imaging
Incidental Diagnosis
Radical Cholecystectomy
Targetable Alterations
Chemoimmunotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Gallbladder Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gallbladder Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gallbladder Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gallbladder Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gallbladder Cancer Conference 2027 — FAQs
What is the Gallbladder Cancer track at CIOC 2027?
The Gallbladder Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gallbladder Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gallbladder Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Gallbladder Cancer are all welcome — whether presenting or attending.
Can I present my research in the Gallbladder Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gallbladder Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gallbladder Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.